Ozempic 00169-4181-13
Generic: Semaglutide
- Manufacturer
- Novo Nordisk Pharmaceutical Industries, Lp
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 7, 2022
- Listing Expires
- December 31, 2027
- Application
- NDA209637
Need to source Ozempic? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Semaglutide | .68 mg/mL |
Drug Class
GLP-1 Receptor Agonist [EPC]GLP-1 Receptor Agonist [EPC]Glucagon-Like Peptide 1 [CS]
Selected Package
00169-4181-13Selected1 SYRINGE, PLASTIC in 1 CARTON (0169-4181-13) / 3 mL in 1 SYRINGE, PLASTIC (0169-4181-03)
Other packages for this product(1)
1 SYRINGE, PLASTIC in 1 CARTON (0169-4181-97) / 3 mL in 1 SYRINGE, PLASTIC (0169-4181-90)